Kite Pharma, Inc.;The United States of America, as Represented by the Secretary, Department of Health and Human Servic
发明人:
Arianne PEREZ,Marianna Sabatino,Steven A. Rosenberg,Nicholas P. Restifo
申请号：
US16533109
公开号：
US20200206265A1
申请日:
2019.08.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are methods for delaying or inhibiting T cell maturation or differentiation in vitro for a T cell therapy, comprising contacting one or more T cells from a subject in need of a T cell therapy with an AKT inhibitor and at least one of exogenous Interleukin-7 (IL-7) and exogenous Interleukin-15 (IL-15), wherein the resulting T cells exhibit delayed maturation or differentiation. In some embodiments, the method further comprises administering the one or more T cells to a subject in need of a T cell therapy.
